nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-4840478C·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: Aging·Basis: Full text·Type: Prediction or prognostic modeling

Plasma proteomic signatures of cellular aging predict human disease.

Ding et al.Ding, Bot, Chen et al.·2026·Nature medicine·10.1038/s41591-026-04446-y ↗

Primary claim

Cellular aging signatures were associated with disease status and predicted incident disease and mortality over 15 years of follow-up.

Tentative · hazard associations support stratification, but predictive discrimination, calibration and incremental value were not reported
In brief

Large-scale plasma proteomics links putative cell-specific aging signatures to disease and mortality, but missing prognostic baselines limits predictive interpretation.

ReliabilityCaveats3 of 4 checks completeRead the 2 entries ↓
Possible — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.
Abstract

Aging is asynchronous across cells and organs. Here we tested whether plasma proteomics can be used to analyze cell type-specific aging. From analyses of over 7,000 plasma proteins measured in 60,542 individuals, we developed machine learning models to estimate the biological age of over 40 cell types spanning neuronal, immune, glial, endocrine, epithelial and musculoskeletal origins. We observed that 20-25% of individuals exhibited accelerated aging in a single cell type and 1-3% in 10 or more cell types. Cellular aging signatures were associated with disease status and predicted incident disease and mortality over 15 years of follow-up. Individuals with the APOE4 genotype showed older astrocytes but younger macrophages compared to APOE3 carriers, whereas the APOE2 genotype had inverse associations. Moreover, extreme astrocyte aging tripled the risk of incident Alzheimer's Disease in individuals with two APOE4 alleles, while youthful astrocytes reduced risk. Individuals with extremely aged compared to youthful skeletal myocytes exhibited a 12.7-fold higher risk of developing amyotrophic lateral sclerosis. In individuals who smoked, extreme respiratory epithelial cell aging was associated with a 58% higher lung cancer risk compared to smoking alone. Specific cellular vulnerabilities and cumulative cellular aging burden influenced survival, with youthful immune and neuronal cell types conferring protective effects. Finally, we developed a polycellular aging risk score that stratified mortality risk across cohorts and proteomics platforms. These findings establish a framework for quantifying human physiology at cellular resolution, revealing heterogeneous aging trajectories and their impact on disease susceptibility and resilience.

Key Claims

Primary finding · Tentative

Cellular aging signatures were associated with disease status and predicted incident disease and mortality over 15 years of follow-up.

Possible — the claim's weakest requirement is that the effect exists at all. Experimental. Every point below is traceable to a quoted passage, but this forecast has not yet been validated against known replication outcomes.

hazard associations support stratification, but predictive discrimination, calibration and incremental value were not reported

Abstract
Quote verified
Secondary · Tentative

Individuals with extremely aged compared to youthful skeletal myocytes exhibited a 12.7-fold higher risk of developing amyotrophic lateral sclerosis.

the reported association uses a small youthful reference group with uncertain event counts and estimate stability

Abstract; Results, incident ALS; Fig. 3c
Quote verified
Secondary · Supported

Extreme astrocyte aging tripled the risk of incident Alzheimer's Disease in individuals with two APOE4 alleles, while youthful astrocytes reduced risk.

cumulative incidence supports the threefold contrast, though the youthful APOE4/4 group contained only 23 participants

Abstract; Results, APOE-stratified AD analysis; Fig. 3e
Quote verified
Secondary · Supported

In individuals who smoked, extreme respiratory epithelial cell aging was associated with a 58% higher lung cancer risk compared to smoking alone.

the reported hazards support the contrast, with observational adjustment rather than clinical prediction testing

Abstract; Results, lung cancer; Fig. 4a
Quote verified
Secondary · Tentative

We developed a polycellular aging risk score that stratified mortality risk across cohorts and proteomics platforms.

one external cohort and cohort-specific percentile thresholds support stratification but not platform-agnostic deployment

Abstract; Results, PARS; Fig. 5e–f
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Large multi-cohort longitudinal evidence base

The analysis covers 60,542 individuals across GNPC, UKB and NSHD, with prospective disease and mortality follow-up in UKB and repeated measurements in NSHD.

↳ Main, study overview; Results; Figs. 1, 3–5

#methodological rigour

Held-out and cross-platform evaluation

Olink clocks and PARS were developed in the UKB training partition and evaluated in a held-out test partition, while PARS was also applied to SomaScan measurements in NSHD.

↳ Methods, Cellular Age Estimation and PARS Development; Fig. 5e–f

#methodological rigour

Targeted adjustments and sensitivity analyses

The study benchmarks astrocyte aging against APOE4, PRS and age, adjusts respiratory signatures for smoking exposure, and repeats the ALS analysis after a three-year diagnostic lag.

↳ Fig. 3f; Extended Data Figs. 6 and 9; Methods, Prognostic Analysis

Limitations

#methodological rigour

Prediction lacks essential performance benchmarks

The disease and mortality analyses emphasize hazard ratios and survival separation without reporting discrimination, calibration or broad comparisons against established clinical and general proteomic prognostic models.

↳ Results, Figs. 3–5; Methods, Prognostic Analysis and PARS Development

#methodological rigour

Cell specificity remains unisolated

The analysis does not compare the assigned panels with matched random protein sets, whole-proteome models or organ clocks, so the endpoint value attributable to cell-type mapping is unresolved.

↳ Methods, Identification of Cell Type-Enriched Plasma Proteins and Cellular Age Estimation

#positioning

Cellular interpretation exceeds source evidence

The Discussion acknowledges that plasma proteins may be produced or released more broadly, yet the conclusions retain cellular-resolution and therapeutic interpretations.

↳ Discussion, limitations and conclusion

Does this match your read? Add your assessment ↓

Nabu Commentary

The study's strongest features are its scale, center-based UKB train-test design, prospective follow-up and application of PARS across Olink and SomaScan. Its methodological score is constrained because hazard ratios and Kaplan–Meier curves do not establish prediction quality without discrimination, calibration and fair prognostic comparators. The absence of matched non-cell-specific or organ-clock analyses also leaves the added value of cell-type assignment unresolved. The paper acknowledges plasma-source ambiguity, but its cellular-resolution and therapeutic framing remains broader than that limitation supports.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
3.0±0.2

Contribution
3.9

The study meaningfully extends plasma aging-clock work to putative cell-type signatures across 60,542 participants, three cohorts and two assay platforms. The advance is tempered by the absence of direct endpoint comparisons with organ-level or general proteomic clocks.

Main, study overview; Results, cellular aging model development; Figs. 3–5

We map plasma proteins to their putative cellular origin and construct computational models that measure the biological age of over 40 cell types.

Methodological Rigour
2.4

The UKB center-based train-test split, bootstrap aggregation, disease-specific adjustments and NSHD evaluation support the analysis. The central prediction framing lacks discrimination, calibration and broad prognostic baselines, while no matched ablation establishes that cell-type assignment adds endpoint-relevant information.

Methods, Cellular Age Estimation; Prognostic Analysis of Incident Disease; PARS Development; Figs. 3–5

Participants were stratified into high, medium, and low risk groups based on cohort-specific score distributions.

Reporting
3.3

The manuscript follows a coherent progression from protein mapping and clock construction to disease, mortality and PARS analyses. However, statements that the signatures predict or strongly prognosticate disease imply validated predictive performance beyond the reported hazard and survival separation analyses.

Abstract; Results, cancer and chronic disease prognosis; Discussion

Our findings reveal cellular aging signatures strongly prognosticate future disease.

Positioning
3.0

The paper positions the work against organ-level and tissue-based aging clocks and acknowledges transcript-to-protein and population limitations. Its conclusions nevertheless retain cellular-resolution and therapeutic interpretations that the plasma-source ambiguity materially narrows.

Main, prior-work framing; Discussion, limitations and conclusion

Plasma proteins arise from multiple cellular processes not explicitly disentangled here.

Reliability

Caveats3 of 4 checks


Results checkNoted

One reported value does not reconcile, but the key claims do not rest on it.

Reporting and transparencyNoted

The NSHD longitudinal mortality methods describe deaths as censoring, whereas the figure caption describes death as the event; the supplied text does not establish how the analysis actually encoded deaths.

Ethics approval: declared · Data availability: declared

Reference IntegrityNot checked

Reference integrity check could not run: references could not be reliably parsed from the manuscript; verification skipped rather than risk false verdicts.

0 references in manuscript

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Generic health relevance
Type of advanceMethodological
Route to useSuggested
AdvanceExtends
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessValidated
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The prognostic claim was tested prospectively in three independent cohorts across two proteomics platforms, with external validation in the NSHD cohort and 15-year follow-up, but not in routine clinical use.

From the paper
“underscoring potential for targeted surveillance and early preventive interventions”

The paper names real-world uses of its findings, such as presymptomatic detection, risk stratification and targeted surveillance, but does not specify which professionals or organisations would apply them.

Pathway

Clinicians could use these plasma-based cellular aging scores as blood biomarkers to stratify patients for presymptomatic disease screening and targeted preventive surveillance.

Barrier

The associations need prospective demonstration that risk stratification changes clinical management or outcomes, plus validation in younger and more diverse populations before clinical adoption.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. Associations of proteomic age clocks with lifestyle risk factors, incident chronic diseases and mortality in two European cohorts

    Robinson, Xiao, Homann, et al. · 2026 · Clinical medicine

    Primary claim

    the global age gap, an age acceleration score combining proteomic clocks, was associated with smoking, alcohol consumption, physical inactivity and higher risk of mortality, cardiovascular diseases, dementia and cancers of the liver, upper aero-digestive tract, lung and kidney.

    Supported
    Evidence Score
    3.8±0.2
    Reliability
    Caveats
  2. Efficient differential expression analysis of large-scale single-cell transcriptomics data using Dreamlet

    2026 · Biological sciences

    Primary claim

    Designed for data from large cohorts, dreamlet is substantially faster and uses less memory than existing workflows, while supporting complex statistical models and controlling the false positive rate.

    Tentative
    Evidence Score
    4.0±0.2
    Reliability
    Caveats
  3. Tracing the spread of Germanic languages using ancient genomics

    2026 · Biological sciences

    Primary claim

    we identify an archaeologically elusive population that entered Sweden, likely from the Baltic region, by around 4000 bp

    Supported
    Evidence Score
    3.4±0.2
    Reliability
    No concerns

How the rubric works →